Hercules Capital, Inc.HTGC
Hercules Capital, Inc. Commitments Disclosure
Commitments and Contingencies
The Company’s commitments and contingencies consist primarily of unfunded commitments to extend credit in the form of loans to the Company’s portfolio companies. As of December 31, 2025, a portion of these unfunded contractual commitments are dependent upon the portfolio company reaching certain milestones before the debt commitment becomes available. Furthermore, the Company’s credit agreements with its portfolio companies generally contain customary lending provisions which allow the Company relief from funding obligations for previously made unfunded commitments in instances where the underlying portfolio company experiences materially adverse events that affect the financial condition or business outlook for the portfolio company. Since a portion of these commitments may expire without being drawn, unfunded contractual commitments do not necessarily represent future cash requirements. As such, the Company’s disclosure of unfunded contractual commitments includes only those which are available at the request of the portfolio company and unencumbered by future or unachieved milestones.
As of December 31, 2025 and December 31, 2024, the Company had approximately $385.6 million and $448.5 million, respectively, of available unfunded commitments, including undrawn revolving facilities, which were available at the request of the portfolio company and unencumbered by future or unachieved milestones. In order to draw a portion of the Company's available unfunded commitments, a portfolio company must submit to the Company a formal funding request that complies with the applicable advance notice and other operational requirements. The amounts disclosed exclude unfunded commitments (i) for which, with respect to a portfolio company's agreement, a milestone was achieved after the last day on which the portfolio company could have requested a drawdown funding to be completed within the reporting period; and (ii) related to the portion of portfolio company investments assigned to or directly committed by the Adviser Funds as described in “Note 13 - Related Party Transactions”. The fair value of the Company’s unfunded commitments is considered to be immaterial as the yield determined at the time of underwriting is expected to be materially consistent with the yield upon funding, given that interest rates are generally pegged to market indices and given the existence of milestones, conditions and/or obligations embedded in the borrowing agreements.
As of December 31, 2025 and December 31, 2024, the Company’s unfunded contractual commitments available at the request of the portfolio company, including undrawn revolving facilities, and unencumbered by milestones were as follows:
| (in thousands) | Unfunded Commitments (1) as of | |||||||||||||
| Portfolio Company | December 31, 2025 | December 31, 2024 | ||||||||||||
| Debt Investments: | ||||||||||||||
| Earnix, Inc. | $ | 26,250 | $ | 41,250 | ||||||||||
| ChenMed, LLC | 25,000 | — | ||||||||||||
| Disc Medicine, Inc. | 22,500 | 22,500 | ||||||||||||
| Saronic Technologies, Inc. | 21,250 | — | ||||||||||||
| Arcus Biosciences, Inc. | 18,750 | 37,500 | ||||||||||||
| GoEuro Travel GmbH | 18,750 | 26,250 | ||||||||||||
| Curana Health Holdings, LLC | 17,500 | 7,500 | ||||||||||||
| Mango Technologies, Inc. | 16,750 | — | ||||||||||||
| Harness, Inc. | 14,438 | 11,550 | ||||||||||||
| Weee! Inc. | 12,500 | — | ||||||||||||
| Viridian Therapeutics, Inc. | 12,250 | 8,000 | ||||||||||||
| Alector, Inc. | 10,500 | 10,500 | ||||||||||||
| CoreView USA, Inc. | 10,000 | 10,000 | ||||||||||||
| DroneDeploy, Inc. | 10,000 | 625 | ||||||||||||
| Peek Travel, Inc. | 9,750 | — | ||||||||||||
| Marathon Health, LLC | 9,620 | 24,250 | ||||||||||||
| DocPlanner | 9,538 | — | ||||||||||||
| Finix Payments, Inc. | 8,750 | — | ||||||||||||
| ZeroEyes, Inc. | 8,000 | — | ||||||||||||
| Pindrop Security, Inc. | 7,750 | 19,375 | ||||||||||||
| Elation Health, Inc. | 7,500 | — | ||||||||||||
| Imagen Technologies, Inc. | 7,500 | — | ||||||||||||
| Nerdy Inc. | 7,000 | — | ||||||||||||
| Loft Orbital Solutions Inc. | 6,600 | — | ||||||||||||
| iSpot.tv, Inc. | 5,980 | — | ||||||||||||
| Distributed Creation Inc. | 5,000 | — | ||||||||||||
| (in thousands) | Unfunded Commitments (1) as of | |||||||||||||
| Portfolio Company | December 31, 2025 | December 31, 2024 | ||||||||||||
| DNSFilter, Inc. | $ | 5,000 | $ | — | ||||||||||
| Smartsheet Inc. | 4,840 | — | ||||||||||||
| PayIt, LLC | 4,800 | 8,000 | ||||||||||||
| Babel Street | 3,275 | 4,367 | ||||||||||||
| Loftware, Inc. | 2,846 | 2,277 | ||||||||||||
| Funnel Holding AB (publ) | 2,625 | — | ||||||||||||
| Zappi, Inc. | 2,571 | 2,571 | ||||||||||||
| Octave Health Group, Inc. | 2,500 | — | ||||||||||||
| Tidal Vision Products, Inc. | 2,500 | — | ||||||||||||
| Carbyne, Inc. | 2,334 | — | ||||||||||||
| Proven Optics, LLC | 2,250 | — | ||||||||||||
| New Relic, Inc. | 2,176 | 2,176 | ||||||||||||
| Streamline Healthcare Solutions | 2,100 | 2,200 | ||||||||||||
| Behavox Limited | 2,100 | — | ||||||||||||
| Sumo Logic, Inc. | 2,000 | 2,000 | ||||||||||||
| Akeyless Security Ltd. | 2,000 | — | ||||||||||||
| Saama Technologies, LLC | 1,938 | 3,875 | ||||||||||||
| LogicSource | 1,209 | 1,209 | ||||||||||||
| Zimperium, Inc. | 1,087 | 196 | ||||||||||||
| Alchemer LLC | 890 | — | ||||||||||||
| Dispatch Technologies, Inc. | 625 | 563 | ||||||||||||
| LinenMaster, LLC | 338 | 1,000 | ||||||||||||
| ShadowDragon, LLC | 333 | 333 | ||||||||||||
| TaxCalc | 311 | 1,166 | ||||||||||||
| Omeda Holdings, LLC | 160 | 731 | ||||||||||||
| Thumbtack, Inc. | — | 30,000 | ||||||||||||
| Armis, Inc. | — | 25,000 | ||||||||||||
| Coronet Cyber Security Ltd. | — | 17,000 | ||||||||||||
| Locus Robotics Corp. | — | 16,250 | ||||||||||||
| Akero Therapeutics, Inc. | — | 15,000 | ||||||||||||
| Dragos, Inc. | — | 13,000 | ||||||||||||
| Aryaka Networks, Inc. | — | 12,500 | ||||||||||||
| WellBe Senior Medical, LLC | — | 12,000 | ||||||||||||
| Strive Health Holdings, LLC | — | 8,299 | ||||||||||||
| Suzy, Inc. | — | 8,000 | ||||||||||||
| Heron Therapeutics, Inc. | — | 8,000 | ||||||||||||
| ATAI Life Sciences N.V. | — | 7,000 | ||||||||||||
| Dashlane, Inc. | — | 5,000 | ||||||||||||
| AlphaSense, Inc. | — | 4,000 | ||||||||||||
| Allvue Systems, LLC | — | 3,590 | ||||||||||||
| LogRhythm, Inc. | — | 3,143 | ||||||||||||
| Ceros, Inc. | — | 1,707 | ||||||||||||
| 3GTMS, LLC | — | 886 | ||||||||||||
| Main Street Rural, Inc. | — | 874 | ||||||||||||
| Fortified Health Security | — | 840 | ||||||||||||
| Flight Schedule Pro, LLC | — | 646 | ||||||||||||
| Total Unfunded Debt Commitments: | 382,234 | 444,699 | ||||||||||||
| (in thousands) | Unfunded Commitments (1) as of | |||||||||||||
| Portfolio Company | December 31, 2025 | December 31, 2024 | ||||||||||||
Investment Funds & Vehicles(2) | ||||||||||||||
| Forbion Growth Opportunities Fund I C.V. | $ | 1,771 | $ | 1,757 | ||||||||||
| Forbion Growth Opportunities Fund II C.V. | 1,618 | 2,072 | ||||||||||||
| Total Unfunded Commitments in Investment Funds & Vehicles: | 3,389 | 3,829 | ||||||||||||
| Total Unfunded Commitments | $ | 385,623 | $ | 448,528 | ||||||||||
(1)For debt investments, amounts represent unfunded commitments, including undrawn revolving facilities, which are available at the request of the portfolio company. Amount excludes unfunded commitments which are unavailable due to the borrower having not met certain milestones. These amounts also exclude $96.2 million and $139.7 million of unfunded commitments as of December 31, 2025 and December 31, 2024, respectively, to portfolio companies related to loans assigned to or directly committed by the Adviser Funds as described in “Note 13 - Related Party Transactions”.
(2)For investment funds and vehicles, the amount represents uncalled capital commitments in private equity funds.
The following table provides additional information on the Company’s unencumbered unfunded commitments regarding milestones, expirations and type:
| (in thousands) | December 31, 2025 | December 31, 2024 | |||||||||
| Unfunded Debt Commitments: | |||||||||||
| Expiring during: | |||||||||||
| 2025 | $ | — | $ | 251,941 | |||||||
| 2026 | 281,807 | 147,840 | |||||||||
| 2027 | 41,112 | 10,553 | |||||||||
| 2028 | 4,361 | 6,040 | |||||||||
| 2029 | 16,588 | 24,149 | |||||||||
| 2030 | 33,526 | 4,176 | |||||||||
| 2031 | 4,840 | — | |||||||||
| Total Unfunded Debt Commitments | 382,234 | 444,699 | |||||||||
| Unfunded Commitments in Investment Funds & Vehicles: | |||||||||||
| Expiring during: | |||||||||||
| 2030 | 1,771 | 1,757 | |||||||||
| 2032 | 1,618 | 2,072 | |||||||||
| Total Unfunded Commitments in Investment Funds & Vehicles | 3,389 | 3,829 | |||||||||
| Total Unfunded Commitments | $ | 385,623 | $ | 448,528 | |||||||
The following tables provide the Company’s contractual obligations as of December 31, 2025 and December 31, 2024:
| As of December 31, 2025: | Payments due by period (in thousands) | |||||||||||||||||||||||||||||||
Contractual Obligations(1) | Total | Less than 1 year | 1 - 3 years | 3 - 5 years | After 5 years | |||||||||||||||||||||||||||
Debt(2)(3) | $ | 2,313,070 | $ | 425,000 | $ | 637,500 | $ | 795,934 | $ | 454,636 | ||||||||||||||||||||||
Lease and License Obligations(4) | 20,892 | 3,339 | 6,228 | 5,586 | 5,739 | |||||||||||||||||||||||||||
| Total | $ | 2,333,962 | $ | 428,339 | $ | 643,728 | $ | 801,520 | $ | 460,375 | ||||||||||||||||||||||
| As of December 31, 2024: | Payments due by period (in thousands) | |||||||||||||||||||||||||||||||
Contractual Obligations(1) | Total | Less than 1 year | 1 - 3 years | 3 - 5 years | After 5 years | |||||||||||||||||||||||||||
Debt(3)(5) | $ | 1,783,265 | $ | 170,000 | $ | 891,000 | $ | 283,790 | $ | 438,475 | ||||||||||||||||||||||
Lease and License Obligations(4) | 23,976 | 3,246 | 6,640 | 5,589 | 8,501 | |||||||||||||||||||||||||||
| Total | $ | 1,807,241 | $ | 173,246 | $ | 897,640 | $ | 289,379 | $ | 446,976 | ||||||||||||||||||||||
(1)Excludes commitments to extend credit to the Company’s portfolio companies and uncalled capital commitments in investment funds.
(2)Includes $350.0 million in principal outstanding under the SBA Debentures, $50.0 million of the March 2026 A Notes, $50.0 million of the March 2026 B Notes, $350.0 million of the June 2030 Notes, $64.6 million of the 2031 Asset-Backed Notes, $40.0 million of the 2033 Notes, $325.0 million of the September 2026 Notes, $350.0 million of the January 2027 Notes and $287.5 million of the 2028 Convertible Notes as of December 31, 2025. There was also $277.9 million outstanding under the SMBC Facility and $168.0 million outstanding under the MUFG Bank Facility as of December 31, 2025.
(3)Amounts represent future principal repayments and not the carrying value of each liability. See “Note 5 – Debt”.
(4)Leases and license obligations includes contractual amounts related to short-term leases.
(5)Includes $279.0 million in principal outstanding under the SBA Debentures, $50.0 million of the February 2025 Notes, $70.0 million of the June 2025 Notes, $50.0 million of the June 2025 3-Year Notes, $50.0 million of the March 2026 A Notes, $50.0 million of the March 2026 B
Notes, $119.5 million of the 2031 Asset-Backed Notes, $40.0 million of the 2033 Notes, $325.0 million of the September 2026 Notes and $350.0 million of the January 2027 Notes as of December 31, 2024. There was also $283.8 million outstanding under the SMBC Facility and $116.0 million outstanding under the MUFG Bank Facility as of December 31, 2024.
Certain premises are leased or licensed under agreements which expire at various dates through July 2034. Total rent expense, including short-term leases, amounted to approximately $3.4 million, $3.5 million, and $3.4 million, during the years ended December 31, 2025, 2024, and 2023, respectively. The Company recognizes an operating lease liability and a ROU asset for all leases, with the exception of short-term leases. The lease payments on short-term leases are recognized as rent expense on a straight-line basis. The discount rate applied to measure each ROU asset and lease liability is based on the Company’s incremental weighted average cost of debt. The Company considers the general economic environment and its credit rating and factors in various financing and asset specific adjustments to ensure the discount rate applied is appropriate to the intended use of the underlying lease. While some of the leases contained options to extend and terminate, it is not reasonably certain that either option will be utilized and therefore, only the payments in the initial term of the leases were included in the lease liability and ROU asset.
The following tables set forth information related to the measurement of the Company’s operating lease liabilities and supplemental cash flow information related to operating leases as of December 31, 2025 and 2024:
| (in thousands) | For the Year Ended December 31, | ||||||||||
| 2025 | 2024 | ||||||||||
| Total operating lease cost | $ | 3,097 | $ | 2,873 | |||||||
| Cash paid for amounts included in the measurement of lease liabilities | 3,087 | 1,865 | |||||||||
| As of December 31, | |||||||||||
| 2025 | 2024 | ||||||||||
| Weighted-average remaining lease term (in years) | 6.94 | 7.81 | |||||||||
| Weighted-average discount rate | 6.91 | % | 6.85 | % | |||||||
The following table shows future minimum lease payments under the Company’s operating leases and a reconciliation to the operating lease liability as of December 31, 2025:
| (in thousands) | As of December 31, 2025 | ||||
| 2026 | $ | 3,179 | |||
| 2027 | 3,452 | ||||
| 2028 | 2,766 | ||||
| Thereafter | 11,324 | ||||
| Total lease payments | 20,721 | ||||
| Less: imputed interest & other items | (4,454) | ||||
| Total operating lease liability | $ | 16,267 | |||
The Company may, from time to time, be involved in litigation arising out of its operations in the normal course of business or otherwise. Furthermore, third parties may try to seek to impose liability on the Company in connection with the activities of its portfolio companies. While the outcome of any current legal proceedings cannot at this time be predicted with certainty, the Company does not expect any current matters will materially affect the Company’s financial condition or results of operations; however, there can be no assurance whether any pending legal proceedings will have a material adverse effect on the Company’s financial condition or results of operations in any future reporting period.
Free Sentinel
Track for freeWant the next Hercules Capital, Inc. commitments disclosure the moment it drops?
Set a Sentinel and we'll alert you the moment Hercules Capital, Inc.'s next filing hits EDGAR. No credit card, your email never gets sold.
Historical Timeline
| Fiscal Year | Filed | |
|---|---|---|
| 2025 | Feb 12, 2026 | Showing above |
| 2024 | Feb 13, 2025 | |
| 2023 | Feb 15, 2024 | |
| 2022 | Feb 16, 2023 | |
About Commitments Disclosures
Commitments and contingencies disclosures catalog a company's off-balance-sheet obligations and legal exposures — purchase commitments, guarantee arrangements, pending litigation, and regulatory proceedings. These items represent potential future cash outflows that may not appear as liabilities on the balance sheet until they become probable and estimable.
Key signals: litigation reserves and disclosed loss ranges quantify management's estimate of legal exposure, but unquantified "reasonably possible" losses often represent the larger risk. Watch for changes in language around pending cases — shifts from "remote" to "reasonably possible" or increases in estimated loss ranges signal deteriorating outcomes. Unconditional purchase obligations and take-or-pay contracts create fixed cost structures that reduce operational flexibility. Guarantee arrangements for subsidiaries or joint ventures can create cascading obligations. Compare the total commitment schedule against projected free cash flow to assess whether the company can meet its obligations without additional financing.